Education
About Us
Working with TipRanks
Follow Us
K Pharma,Inc. (JP:4896)
:4896
4896 Stock Chart & Stats
¥651.00
¥14.00(2.16%)
At close: 4:00 PM EST
¥651.00
¥14.00(2.16%)
Day’s Range― - ―
52-Week Range¥537.00 - ¥1,420.00
Previous CloseN/A
Volume10.50K
Average Volume (3M)48.08K
Market Cap
¥8.01B
Enterprise Value¥4.94B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.86
Next Earnings
Feb 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-20.44
Shares Outstanding11,609,600
10 Day Avg. Volume47,520
30 Day Avg. Volume48,080
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)3.19
Price to Sales (P/S)0.00
P/FCF Ratio-7.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
4896 FAQ
What was K Pharma,Inc.’s price range in the past 12 months?
K Pharma,Inc. lowest stock price was ¥537.00 and its highest was ¥1420.00 in the past 12 months.
What is K Pharma,Inc.’s market cap?
K Pharma,Inc.’s market cap is ¥8.01B.
When is K Pharma,Inc.’s upcoming earnings report date?
K Pharma,Inc.’s upcoming earnings report date is Feb 12, 2026 which is in 10 days.
How were K Pharma,Inc.’s earnings last quarter?
K Pharma,Inc. released its earnings results on Nov 12, 2025. The company reported -¥20.44 earnings per share for the quarter, missing the consensus estimate of N/A by -¥20.44.
Is K Pharma,Inc. overvalued?
According to Wall Street analysts K Pharma,Inc.’s price is currently Overvalued.
Does K Pharma,Inc. pay dividends?
K Pharma,Inc. does not currently pay dividends.
What is K Pharma,Inc.’s EPS estimate?
K Pharma,Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does K Pharma,Inc. have?
K Pharma,Inc. has 11,609,600 shares outstanding.
What happened to K Pharma,Inc.’s price movement after its last earnings report?
K Pharma,Inc. reported an EPS of -¥20.44 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.969%.
Which hedge fund is a major shareholder of K Pharma,Inc.?
Currently, no hedge funds are holding shares in JP:4896
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
K Pharma,Inc.
K Pharma,Inc. engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan. It develops regenerative medicine products using disease-specific induced pluripotent stem (iPS) cell technology for spinal cord injuries and cerebral infarctions. The company was incorporated in 2016 and is based in Minato, Japan.
Technical Analysis
Immuno-Biological Laboratories Co., Ltd.
―
Oncolys BioPharma, Inc.
―
Ribomic, Inc.
―
BrightPath Biotherapeutics Co.Ltd.
―
Kringle Pharma, Inc.
―